Continuing Care and Treatment for Patients With Cancer/AIDS/Skin Disease

Continuing Treatment for Children and Adults in the Center for Cancer Research

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT00001295

Enrollment

2145

Registered

1999-11-04

Start date

1992-01-29

Completion date

2016-08-23

Last updated

2019-12-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer, HIV

Keywords

Follow-Up, Treatment

Brief summary

This protocol is to provide continuing medical/surgical/radio-therapeutic care, treatment and follow-up for NCI patients not currently entered on an active research protocol. No investigational treatments will be administered on this protocol.

Detailed description

Background: It may be in the interest of the CCR to continue to follow and treat certain subjects after they have completed their treatment and participation on a research protocol. Objective: To provide continuing treatment and medical follow-up for CCR subjects who have completed their treatment and participation on a research protocol and who are not currently entered on or eligible for another active research protocol. Eligibility: Subjects who have been previously enrolled on and received treatment according to an approved CCR research protocol. (clinical trial) It is in the best interest of the subject and the CCR for the subject to continue to receive standard care and follow-up at the NIH. Design: Medical/surgical/radiotherapeutic care, treatment and follow-up is provided for CCR subjects who have completed their treatment and participation on a research protocol and who are not currently entered on an active research protocol. No investigational treatments will be administered. This protocol is not be used as a platform to perform pilot studies of off-label uses for standard agents.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

No minimum to 99 Years

Healthy volunteers

Inclusion criteria

* INCLUSION CRITERIA: Subjects of any age who have been previously enrolled and treated on an approved CCR research treatment protocol. It is in the best interests of the subject and the CCR for the subject to continue to receive treatment and follow-up at the NIH. The subject or guardian signs the informed consent and agrees to the proposed treatment regimen.

Exclusion criteria

Subjects who have not been previously treated on a CCR research treatment protocol. Subjects who are receiving an investigational therapy.

Design outcomes

Primary

Measure	Time frame
To provide continuing treatment and medical follow-up for CCR subjects who have completed their treatment and participation on a research protocol and who are not currently entered on or eligible for an active research protocol.	Open-ended

Countries

United States

Outcome results